HAEMATOLOGICAL RESPONSE TO DAILY VERSUS INTERMITTENT IRON SUPPLEMENTATION IN MILD TO MODERATE IRON DEFICIENCY ANAEMIA DURING PREGNANCY: A PROSPECTIVE COMPARATIVE STUDY

Main Article Content

Dr Patel Anupam Gangwar
Dr Nirmala Duhan
Dr Devvrat Sai
Dr Jatin Prajapati

Keywords

Iron deficiency anaemia, Pregnancy, Daily iron supplementation, Twice-weekly iron, Hematological response, Hemoglobin, Antenatal care

Abstract

Iron deficiency anaemia (IDA) is one of the most common medical disorders encountered during pregnancy and remains a major contributor to maternal morbidity in low- and middle-income countries. In India, more than half of pregnant women are anaemic, necessitating effective and acceptable iron supplementation strategies. Daily oral iron is the standard regimen; however, gastrointestinal side effects and poor adherence have prompted interest in intermittent dosing. Evaluating hematological response to different supplementation schedules is essential for optimising antenatal care.


Objectives: To compare the hematological response—specifically changes in hemoglobin and hematocrit—to daily versus twice-weekly oral iron supplementation among pregnant women with mild to moderate IDA.


Methods: This prospective, randomized comparative study was conducted at the Department of Obstetrics and Gynaecology, PGIMS Rohtak, Haryana, over 14 months. A total of 200 antenatal women between 14–24 weeks of gestation with mild to moderate IDA were enrolled and randomized into two groups: Group A received daily oral iron (100 mg elemental iron + 500 mcg folic acid), and Group B received twice-weekly supplementation with the same formulation. Clinical evaluation and laboratory investigations, including hemoglobin and hematocrit estimation, were performed at enrolment and every 4 weeks until delivery. Compliance and adverse effects were assessed at each visit. Data were analysed using unpaired t-test and Chi-square test, with p < 0.05 considered statistically significant.


Results: Baseline characteristics were comparable between groups. Hemoglobin increased steadily in both groups, with no statistically significant difference at any time point (p > 0.05). Percentage improvement in hemoglobin was also similar across follow-ups. Hematocrit showed a parallel rising trend in both groups, with a significant difference observed only at 16 weeks, where Group B demonstrated a higher percentage increase (p = 0.013). Overall, both regimens produced comparable hematological improvement, indicating non-inferiority of twice-weekly dosing.


Conclusion: Daily and twice-weekly oral iron supplementation regimens yield similar hematological outcomes in pregnant women with mild to moderate IDA. Given comparable efficacy, reduced pill burden, and potential for improved adherence, twice-weekly iron supplementation presents a practical alternative to daily dosing in antenatal care programs, particularly in resource-limited settings.

Abstract 0 | PDF Downloads 0

References

1. World Health Organization. Anaemia: fact sheet. News Room, WHO. Available from: https://www.who.int/news-room/fact-sheets/detail/anaemia
2. World Health Organization. Prevalence of anaemia in women of reproductive age (global health indicator). Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-of-anaemia-in-women-of-reproductive-age-(-)
3. World Health Organization. The global prevalence of anaemia in 2019: WHO Global Health Estimates [Internet]. Geneva: WHO; 2023. Available from: https://www.who.int/publications/i/item/9789240088542
4. Milman N. Iron and pregnancy--a delicate balance. Ann Hematol. 2006;85(9):559-565. Available from: https://pubmed.ncbi.nlm.nih.gov/16691399/
5. Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014 Feb;19(2):164-74. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3999603/
6. Ministry of Health & Family Welfare, Government of India. National Family Health Survey (NFHS-5), 2019-21: Phase II Compendium of Fact Sheets (India & 14 States/UTs). New Delhi: MoHFW; 2021. Available from: https://mohfw.gov.in/sites/default/files/NFHS-5_Phase-II_0.pdf
7. Ministry of Health & Family Welfare, Government of India. Anemia Mukt Bharat: Operational Guidelines. New Delhi: MoHFW; 2018. Available from: https://nhm.gov.in/images/pdf/Nutrition/AMB-guidelines/Anemia-Mukt-Bharat-Operational-Guidelines-FINAL.pdf
8. Ministry of Health & Family Welfare, Government of India. Anemia Mukt Bharat: Training Module – T3 Guideline. New Delhi: MoHFW; 2018. Available from: https://nhm.gov.in/images/pdf/Nutrition/AMB-guidelines/T3-Guideline.pdf
9. Pavord S, Daru J, Prasannan N, et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2020. Available from: https://onlinelibrary.wiley.com/doi/10.1111/bjh.16221
10. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PloS one. 2015 Feb 20;10(2):e0117383. Available from: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117383
11. Ganz T. Hepcidin and iron regulation, 10 years later. Blood, The Journal of the American Society of Hematology. 2011 Apr 28;117(17):4425-33. Available from: https://www.sciencedirect.com/science/article/pii/S000649712045195X
12. Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. The Lancet Haematology. 2017 Nov 1;4(11):e524-33. Available from: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(17)30182-5/abstract?_ga=2.99212443.425146944.1558971452-816891290.1558971451
13. Peña‐Rosas JP, De‐Regil LM, Malave HG, Flores‐Urrutia MC, Dowswell T. Intermittent oral iron supplementation during pregnancy. Cochrane database of systematic reviews. 2015(10). Available from: https://pubmed.ncbi.nlm.nih.gov/26482110/
14. Lam MC, Khandakar B, Heon I, et al. Daily versus alternate-day iron supplementation for pregnant women with iron deficiency anemia: a randomized controlled trial. American Journal of Perinatology. 2025 Apr;42(06):699-707. Available from: https://pubmed.ncbi.nlm.nih.gov/39209303/
15. World Health Organization. Intermittent oral iron supplementation during pregnancy. WHO e-Library of Evidence for Nutrition Actions (eLENA). Available from: https://www.who.int/tools/elena/review-summaries/intermittent-iron-pregnancy–intermittent-oral-iron-supplementation-during-pregnancy
16. Mukhopadhyay A, Bhatla N, Kriplani A, Pandey RM, Saxena R. Daily versus intermittent iron supplementation in pregnant women: hematological and pregnancy outcome. Journal of Obstetrics and Gynaecology Research. 2004 Dec;30(6):409-17. Available from: https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/j.1447-0756.2004.00223.x
17. Tandon R, Jain A, Malhotra P. Management of iron deficiency anemia in pregnancy in India. Indian Journal of Hematology and Blood Transfusion. 2018 Apr;34(2):204-15. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC5885006/
18. Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. Bmj. 2013 Jun 21;346. Available from: https://www.ncbi.nlm.nih.gov/books/NBK144160/
19. Moretti D, Stoffel NU. Novel Approaches to Oral Iron Supplementation. InNutritional Anemia 2022 Dec 16 (pp. 295-304). Cham: Springer International Publishing. Available from: https://link.springer.com/chapter/10.1007/978-3-031-14521-6_22

Most read articles by the same author(s)